Skip to search formSkip to main contentSkip to account menu

BVCPP protocol

Known as: Carmustine/Cyclophosphamide/Prednisone/Procarbazine/Vinblastine, BCVPP, BCNU/CTX/PCB/PRED/VBL 
National Institutes of Health

Related topics

Related topics

7 relations

Broader (5)

Antineoplastic Combined Chemotherapy ProtocolsCarmustineCyclophosphamideProcarbazine
PrednisoneProcarbazine Hydrochloride

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2006
Review
2006
MOPPEBVCADChemotherapy with Limited and Conditioned Radiotherapy in Advanced Hodgkin ’ s Lymphoma : 10-Year Results , LateToxicity , and SecondTumors
Purpose: MOPPEBVCAD (mechlorethamine, vincristine, procarbazine, prednisone, epidoxirubicin, bleomycin, vinblastine, lomustine… 
2004
2004
Rituximab affects the prognosis of patients with nonHodgkin' s lymphomas
Background. Rituximab - the most widely used monoclonal antibody in the B cell lymphoid malignancies - has been applied… 
2000
2000
Radiation dose selection in Hodgkin's disease patients with large mediastinal adenopathy treated with combined modality therapy.
1983
1983
Acute myelogenous leukemia as a second malignant neoplasm following the successful treatment of advanced Hodgkin's disease
For the Southeastern Cancer Study Group Of 209 Hodgkin's disease patients treated at least 6 months with a five‐drug combination… 
1982
1982
Treatment of advanced Hodgkin's disease: 10-year experience in the Eastern Cooperative Oncology group.
Between 1972 and 1981, the Eastern Cooperative Oncology Group completed two major studies of advanced Hodgkin's disease. The… 
1982
1982
Chemotherapy for advanced Hodgkin's disease: conclusions from the Southeastern Cancer Study Group.
The Southeastern Cancer Study Group has explored a variety of approaches to the management of advanced Hodgkin's disease. These… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)